Health Screening: Why Consistency Matters More Than a Perfect Test
Health Screening: Why Consistency Matters More Than a Perfect Test
You did the big screening package. Everything came back clear. You felt relieved, filed the report, and didn’t think about it again for four years.
That relief is the most dangerous part of the whole process.
Does screening actually work?
Yes — when it’s done properly, and the qualifier is doing a lot of work.
Screening finds disease in people who feel completely well. That’s the entire premise, and for certain conditions it clearly saves lives. Colorectal cancer screening finds polyps before they become cancer. Cervical screening has transformed a common cancer into an uncommon one. High blood pressure and high cholesterol produce no symptoms whatsoever until the day they produce a stroke or a heart attack. Diabetes is often silently present for years before diagnosis.
Singapore does reasonably well by international standards — around two-thirds of eligible residents participate in chronic disease screening, and cancer screening rates have recovered to roughly pre-COVID levels. Subsidies exist under Healthier SG for enrolled citizens.
But the participation numbers hide the actual problem.
So what goes wrong?
Four things, and most people have never had any of them explained.
- A clear result is a snapshot, not a guarantee.
Disease develops over time. A test tells you about the day you took it. A normal cholesterol at 45 says nothing about your cholesterol at 50 — and it is the trajectory that predicts risk, not any single value.
This is where screening does its quiet harm. A clear report generates a feeling of safety that lasts far longer than the result does. People stop paying attention. Symptoms get dismissed against the memory of a normal test. The reassurance outlives its validity, and nobody tells you when it expires.
- One-off screening misses the pattern — which is where the information is.
A fasting glucose of 5.4 is normal. A fasting glucose that has gone 4.8 → 5.1 → 5.4 → 5.7 across four years is a person walking steadily toward diabetes, and every single one of those readings was reported as normal.
The same applies to blood pressure creeping upward, kidney function drifting down, liver enzymes edging up, weight climbing 2 kg a year. Individually: normal. As a sequence: a story.
You cannot see a trend from one data point. This is the single strongest argument for screening as a process rather than an event, and it’s the thing episodic testing structurally cannot deliver.
- Standard panels don’t change as you do.
Most people get the same package every time — often whatever their employer’s plan includes, or whatever tier they chose when they booked.
But what you should be screening for changes substantially by decade. In your thirties the priorities are baseline metabolic markers, blood pressure, cervical screening. In your forties, cardiovascular risk becomes real, mammography enters the picture, diabetes risk rises. From fifty, colorectal screening starts, bone health matters, and — genuinely underrated — muscle and functional assessment become worth measuring. In your sixties and beyond, falls risk, cognition, vision and hearing move up the list.
A panel that served you well at 38 may be materially wrong at 55. And it will never tell you it has become wrong.
- The panel is usually chosen by the wrong thing.
Be honest about how the decision actually gets made: by what the company plan covers, by which package was on promotion, by budget, or by what felt about right on the day.
None of those are medical criteria.
A family history of colorectal cancer at 45 should change your screening schedule. A parent with early heart disease should. Being on medications that affect the kidneys should. A previous abnormal result absolutely should. And yet the panel usually stays whatever it was.
The result is a peculiar inefficiency: people pay for tests they don’t need while missing tests they do. A tumour marker panel that generates anxiety and false positives, alongside no colonoscopy in someone with a clear family history. That isn’t a budget problem. It’s a design problem.
- And none of it works without turning up.
The benefit of screening comes from repeated participation over time. One colonoscopy at 50 and nothing after is not a screening programme. A mammogram in 2019 and none since is not a screening programme.
The most sophisticated panel in the world, done once, is worth less than a basic panel done reliably every year for fifteen years.
What does good screening look like instead?
Five shifts.
Individualised, not packaged. Your panel should follow from your age, sex, family history, existing conditions, medications and risk factors — not from a menu tier. Some people need considerably less than the standard package. Some need considerably more.
Longitudinal, not episodic. Results should sit in one place, compared against your own previous numbers, with the direction of travel visible. Your own history is the most useful reference range you have — far better than a population normal range that spans a wide band of people unlike you.
Scheduled, not spontaneous. Different tests belong on different intervals. A schedule that tells you what’s due and when removes the annual “what should I do this year?” decision, which is where most programmes quietly die.
Adaptive. When something shifts — a new diagnosis, a family history that emerges, a borderline result — the schedule should change in response. Screening plans should be living documents.
Followed up. An abnormal result that nobody chases is worse than no test at all, because it manufactures documented false reassurance.
Platforms now exist that do exactly this — mapping an individualised programme against your risk profile, coordinating the testing and reporting in one place, and tracking your trends over years rather than handing you a fresh PDF each time. It’s a meaningful improvement on the traditional model of an annual package and a folder in a drawer.
Map out your own screening programme
Livolab builds an individualised screening schedule around your age, sex, family history and existing conditions — then coordinates the testing and keeps your results in one place so the trend is visible year on year.
Our clinical insight
Disease develops over time, so screening has to happen over time. A single test, however comprehensive, gives you a snapshot and a feeling of safety with no expiry date printed on it.
What actually reduces risk is a programme: the right tests for your circumstances, repeated at sensible intervals, tracked against your own history, and adjusted as your life changes.
Your screening panel should be dictated by your medical need — not by your budget, your company’s standard plan, or what you happened to feel like doing that day.
Get a screening plan, not a screening package
A screening consultation works out what you specifically should be tested for and how often, based on your history and risk — then sets up a schedule you can actually keep to.
Cresta Medical · 10 Chai Chee Road, #01-01, Singapore 467010
Make your health a priority
Schedule an in-clinic appointment, or speak with Dr Alexis Wong and our care team online — whichever works best for you.